DMII Drugs Made in America Acquisition Ii Corp.
Fundamentals / CIK 0002040475 / USDDrugs Made in America Acquisition Ii Corp. reported $518.7M in total assets and net income of $17.68M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DMII in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$557K Operating profit
-
Net Income FY 2025$17.68M GAAP bottom line
-
Diluted EPS FY 2025-- Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026-- Total debt: --
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 |
|---|---|
| Total Operating Expenses | $488K |
| Operating Income | -$488K |
| Interest Income | $4.93M |
| Net Income | $4.19M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Total Operating Expenses | $77K | $112K | $132K | $235K | $156K | $38K | $59K |
| Operating Income | -$77K | -$112K | -$132K | -$235K | -$156K | -$38K | -$59K |
| Interest Income | $4.70M | $4.51M | $4.44M | -- | $109K | -- | -- |
| Net Income | $4.62M | $4.40M | $4.34M | $4.33M | -$46K | -$38K | -$59K |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $223 | $17K |
| Cash & Short-Term Investments | $223 | $17K |
| Total Current Assets | $26K | $60K |
| Total Non-Current Assets | $504.9M | $78K |
| Total Assets | $505.0M | $138K |
| Accounts Payable | $99K | -- |
| Other Current Liabilities | $0 | -- |
| Total Current Liabilities | $301K | $255K |
| Total Non-Current Liabilities | $17.50M | $0 |
| Total Liabilities | $17.80M | $255K |
| Common Stock | $1.4K | $1.4K |
| Retained Earnings | -$17.78M | -$152K |
| Total Stockholders' Equity | -$17.77M | -$117K |
| Total Equity | -$17.77M | -$117K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | $175K | $348K | $223 | $315K | $17K |
| Cash & Short-Term Investments | -- | $175K | $348K | $223 | $315K | $17K |
| Total Current Assets | $140K | $218K | $352K | $26K | $896K | $60K |
| Total Non-Current Assets | $518.6M | $513.9M | $509.4M | $504.9M | $500.1M | $78K |
| Total Assets | $518.7M | $514.1M | $509.7M | $505.0M | $501.0M | $138K |
| Accounts Payable | $79K | $12K | $49K | $99K | $4.6K | -- |
| Short-Term Debt | -- | $450K | $450K | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | $0 | $554K | -- |
| Total Current Liabilities | $643K | $645K | $666K | $301K | $677K | $255K |
| Total Non-Current Liabilities | $17.50M | $17.50M | $17.50M | $17.50M | $17.50M | $0 |
| Total Liabilities | $18.14M | $18.14M | $18.17M | $17.80M | $18.18M | $255K |
| Total Debt (incl. Leases) | -- | $450K | $450K | -- | -- | -- |
| Common Stock | $1.4K | $1.4K | $1.4K | $1.4K | $1.6K | $1.4K |
| Retained Earnings | -$18.01M | -$17.93M | -$17.82M | -$17.78M | -$17.28M | -$152K |
| Total Stockholders' Equity | -$18.00M | -$17.93M | -$17.81M | -$17.77M | -$17.28M | -$117K |
| Total Equity | -$18.00M | -$17.93M | -$17.81M | -$17.77M | -$17.28M | -$117K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 |
|---|---|
| Net Income | $4.19M |
| Change in Payables | $99K |
| Operating Cash Flow | -$1.02M |
| Investing Cash Flow | -$500.0M |
| Financing Cash Flow | $501.0M |
| Net Change in Cash | -$17K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Net Income | $4.62M | $4.40M | $4.34M | $4.33M | -$46K | -$38K | -$59K |
| Change in Payables | -- | -$22K | -$22K | $95K | $2.4K | -$9.1K | $11K |
| Operating Cash Flow | -$57K | -$173K | -$103K | -$315K | -$691K | -$2.6K | -$10K |
| Financing Cash Flow | $0 | $0 | $450K | -- | -- | -- | -- |
| Net Change in Cash | -$57K | -$173K | $347K | -$315K | $311K | -$2.6K | -$10K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 |
|---|---|
| Return on Assets (ROA) | 0.8% |
| Current Ratio | 0.09x |
| Quick Ratio | 0.00x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | 3.4% | 2.5% | 1.7% | 0.8% | -- | -- | -- |
| Current Ratio | 0.22x | 0.34x | 0.53x | 0.09x | 1.32x | -- | -- |
| Quick Ratio | -- | 0.27x | 0.52x | 0.00x | 0.47x | -- | -- |